188 related articles for article (PubMed ID: 1818759)
1. Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled clinical study.
Lyritis GP; Tsakalakos N; Magiasis B; Karachalios T; Yiatzides A; Tsekoura M
Calcif Tissue Int; 1991 Dec; 49(6):369-72. PubMed ID: 1818759
[TBL] [Abstract][Full Text] [Related]
2. Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: a prospective double-blind, randomized, placebo-controlled clinical study.
Lyritis GP; Ioannidis GV; Karachalios T; Roidis N; Kataxaki E; Papaioannou N; Kaloudis J; Galanos A
Clin J Pain; 1999 Dec; 15(4):284-9. PubMed ID: 10617256
[TBL] [Abstract][Full Text] [Related]
3. Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebo-controlled clinical study.
Lyritis GP; Paspati I; Karachalios T; Ioakimidis D; Skarantavos G; Lyritis PG
Acta Orthop Scand Suppl; 1997 Oct; 275():112-4. PubMed ID: 9385283
[TBL] [Abstract][Full Text] [Related]
4. Analgesic effect of nasal salmon calcitonin during the early post-fracture period of the distal radius fracture.
Karponis A; Rizou S; Pallis D; Zafeiris CP; Georgiou DF; Galanos A; Giannoulis F; Lyritis GP
J Musculoskelet Neuronal Interact; 2015 Jun; 15(2):186-9. PubMed ID: 26032211
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin in the treatment of osteoporotic bone pain.
Rifat SF; Kiningham RB; Peggs JF
J Fam Pract; 1992 Jul; 35(1):93-6. PubMed ID: 1613479
[TBL] [Abstract][Full Text] [Related]
6. Equivalence of nasal spray and subcutaneous formulations of salmon calcitonin.
Combe B; Cohen C; Aubin F
Calcif Tissue Int; 1997 Jul; 61(1):10-5. PubMed ID: 9192504
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
Chesnut CH; Silverman S; Andriano K; Genant H; Gimona A; Harris S; Kiel D; LeBoff M; Maricic M; Miller P; Moniz C; Peacock M; Richardson P; Watts N; Baylink D
Am J Med; 2000 Sep; 109(4):267-76. PubMed ID: 10996576
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D.
Henriksen K; Byrjalsen I; Andersen JR; Bihlet AR; Russo LA; Alexandersen P; Valter I; Qvist P; Lau E; Riis BJ; Christiansen C; Karsdal MA;
Bone; 2016 Oct; 91():122-9. PubMed ID: 27462009
[TBL] [Abstract][Full Text] [Related]
9. Analgesic efficacy of calcitonin for vertebral fracture pain.
Blau LA; Hoehns JD
Ann Pharmacother; 2003 Apr; 37(4):564-70. PubMed ID: 12659616
[TBL] [Abstract][Full Text] [Related]
10. Analgesic effects of calcitonin.
Lyritis GP; Trovas G
Bone; 2002 May; 30(5 Suppl):71S-74S. PubMed ID: 12008162
[TBL] [Abstract][Full Text] [Related]
11. Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures.
Pun KK; Chan LW
Clin Ther; 1989; 11(2):205-9. PubMed ID: 2660996
[TBL] [Abstract][Full Text] [Related]
12. Synthetic human calcitonin in postmenopausal osteoporosis: a placebo-controlled, double-blind study.
Ljunghall S; Gärdsell P; Johnell O; Larsson K; Lindh E; Obrant K; Sernbo I
Calcif Tissue Int; 1991 Jul; 49(1):17-9. PubMed ID: 1893291
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials.
Knopp JA; Diner BM; Blitz M; Lyritis GP; Rowe BH
Osteoporos Int; 2005 Oct; 16(10):1281-90. PubMed ID: 15614441
[TBL] [Abstract][Full Text] [Related]
14. Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome.
Rico H; Hernandez ER; Revilla M; Gómez-Castresana F
Bone Miner; 1992 Feb; 16(2):131-8. PubMed ID: 1576488
[TBL] [Abstract][Full Text] [Related]
15. Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study.
Gonnelli S; Cepollaro C; Montomoli M; Gennari L; Montagnani A; Palmieri R; Gennari C
Clin Endocrinol (Oxf); 1997 Jan; 46(1):55-61. PubMed ID: 9059558
[TBL] [Abstract][Full Text] [Related]
16. The analgesic role of calcitonin following osteoporotic fracture.
Silverman SL; Azria M
Osteoporos Int; 2002 Nov; 13(11):858-67. PubMed ID: 12415432
[TBL] [Abstract][Full Text] [Related]
17. Managing acute osteoporotic vertebral fractures with calcitonin.
Maksymowych WP
Can Fam Physician; 1998 Oct; 44():2160-6. PubMed ID: 9805171
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
Reginster JY; Deroisy R; Lecart MP; Sarlet N; Zegels B; Jupsin I; de Longueville M; Franchimont P
Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
[TBL] [Abstract][Full Text] [Related]
19. Salmon calcitonin nasal spray treatment for postmenopausal women after hip fracture with total hip arthroplasty.
Peichl P; Marteau R; Griesmacher A; Kumpan W; Schedl R; Prosquil E; Fasol P; Bröll H
J Bone Miner Metab; 2005; 23(3):243-52. PubMed ID: 15838628
[TBL] [Abstract][Full Text] [Related]
20. Analgesic effect of intranasal and intramuscular salmon calcitonin in post-menopausal osteoporosis: a double-blind, double-placebo study.
Pontiroli AE; Pajetta E; Scaglia L; Rubinacci A; Resmini G; Arrigoni M; Pozza G
Aging (Milano); 1994 Dec; 6(6):459-63. PubMed ID: 7748920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]